BASEL, Switzerland, February 4 /PRNewswire/ -- Synosia Therapeutics today announced the appointment of Philippe Lutz MA Finance, as the company's first chief financial officer, effective immediately. He will be based at Synosia's new headquarters in Basel, Switzerland.

Lutz joins Synosia from Credit Suisse Investment Banking where he most recently served as a vice president of the global markets solutions group. In a nine-year career at Credit Suisse, he contributed to a broad range of capital market transactions and successfully completed the chartered financial analyst exams (CFA). Lutz is a Swiss national and earned his masters in business administration from the University of St. Gallen.

TOKYO, February 4 /PRNewswire/ --

- Exhibits to Feature Solutions for Open Internet/Open Platform

- Next Generation Networks and Converged Devices

ACCESS CO., LTD., a global provider of advanced software technologies to the mobile and beyond-PC markets, will be an exhibitor again this year at the GSMA Mobile World Congress 2008 (formerly 3GSM World Congress), the mobile industry's biggest event, which is taking place February 11-14 in Barcelona, Spain. This year's event marks the seventh time that ACCESS will be present at the Mobile World Congress.

LONDON and TOKYO, February 4 /PRNewswire/ --

- LiMo Platform and APIs Open Market Access for Technology Vendors and Application Developers

LiMo Foundation(TM), a global consortium of mobile leaders delivering an open handset platform for the whole industry, today announced the on-schedule availability in March 2008 of the first release of the LiMo Platform-the first globally competitive, Linux-based software platform for mobile handsets-together with the immediate public availability of the application programming interface (API) specifications.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM031LOGO )

LiMo's technology will be showcased in Booth 8b135, Hall 8 at Mobile World Congress (www.mobileworldcongress.com), February 11-14 in Barcelona.

CALGARY, Canada, February 4 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ('Oncolytics') reported today that Dr. Kevin Harrington and his research group at The Institute of Cancer Research, London, U.K. published the results of their work testing combination treatment schedules of reovirus and radiation in human and murine tumour cells in vitro and in vivo. The paper, entitled "Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy" appears online in the February 1, 2008 issue of Clinical Cancer Research.

REDMOND, Washington, February 3 /PRNewswire/ --

The combination of Microsoft and Yahoo! will create a more competitive marketplace by establishing a compelling number two competitor for Internet search and online advertising. The alternative scenarios only lead to less competition on the Internet.

Today, Google is the dominant search engine and advertising company on the Web. Google has amassed about 75 percent of paid search revenues worldwide and its share continues to grow. According to published reports, Google currently has more than 65 percent search query share in the U.S. and more than 85 percent in Europe. Microsoft and Yahoo! on the other hand have roughly 30 percent combined in the U.S. and approximately 10 percent combined in Europe.

LONDON, February 1 /PRNewswire/ -- The Disciplinary Committee of the Royal College of Veterinary Surgeons has this week refused an application for restoration to the Register from a former Hertfordshire veterinary surgeon who was struck off a year ago for being unfit to practise.

Miss Lesley Kay, of Cambridge Road, Sawbridgeworth, was removed from the Register in January 2007 following her multiple convictions for drink-driving offences, driving disqualification and four-month imprisonment.

The original hearing was held in December 2006, but adjourned until January 2007 to allow time for Miss Kay, who admitted suffering from alcoholism, to address her personal problems and to satisfy certain conditions that the Committee laid down.